FDA product code · Clinical chemistry

Densitometeric, Protein Fractionation

Name: FDA decisions, review times, recalls and adverse event reports for product code JQJ
Creator: 510(k) Report

JQJClass I21 CFR 862.1630510(k) exempt1 decision since 19900 recalls

FDA lists JQJ as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 862.9 applies, such as a new intended use or a different fundamental technology. 1 FDA decision since 1990. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of JQJ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · JQJ

FDA has decided no JQJ device since 2007.

Median 510(k) review, days · JQJ

Too few JQJ 510(k)s in any year since 2007 to give a median.

Recalls per year · JQJ

No recall names JQJ since 2007.

Adverse event reports per year · JQJ

No MAUDE report names JQJ since 2007.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	0
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	0
2026	—	—

FIG. 1 — JQJ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JQJ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 862.1630.

CEF Electrophoretic, Protein Fractionation JQK Immunodiffusion, Protein Fractionation

Densitometeric, Protein Fractionation

What has FDA decided in JQJ lately?

Related product codes